{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:16:25Z","timestamp":1740104185928,"version":"3.37.3"},"reference-count":33,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":489,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"crossref","award":["BRG5580005"],"award-info":[{"award-number":["BRG5580005"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Virol."],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1002\/jmv.23957","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T06:26:41Z","timestamp":1398839201000},"page":"1482-1490","source":"Crossref","is-referenced-by-count":20,"title":["<i>IFNL3 (IL28B)<\/i>and<i>IFNL4<\/i>polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6"],"prefix":"10.1002","volume":"86","author":[{"given":"Srunthron","family":"Akkarathamrongsin","sequence":"first","affiliation":[{"name":"Center of Excellence in Clinical Virology; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vo Duy","family":"Thong","sequence":"additional","affiliation":[{"name":"Center of Excellence in Clinical Virology; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunchai","family":"Payungporn","sequence":"additional","affiliation":[{"name":"Department of Biochemistry; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittiyod","family":"Poovorawan","sequence":"additional","affiliation":[{"name":"Department of Medicine; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phisit","family":"Prapunwattana","sequence":"additional","affiliation":[{"name":"Department of Biochemistry; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[{"name":"Center of Excellence in Clinical Virology; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pisit","family":"Tangkijvanich","sequence":"additional","affiliation":[{"name":"Department of Biochemistry; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"key":"10.1002\/jmv.23957-BIB0001|jmv23957-cit-0001","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmv.21680","article-title":"Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand","volume":"82","author":"Akkarathamrongsin","year":"2010a","journal-title":"J Med Virol"},{"key":"10.1002\/jmv.23957-BIB0002|jmv23957-cit-0002","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1872-034X.2010.00702.x","article-title":"High sensitivity assay using serum sample for IL28B genotyping to predict treatment response in chronic hepatitis C patients","volume":"40","author":"Akkarathamrongsin","year":"2010b","journal-title":"Hepatol Res"},{"key":"10.1002\/jmv.23957-BIB0003|jmv23957-cit-0003","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1136\/gutjnl-2012-302019","article-title":"IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5","volume":"61","author":"Antaki","year":"2012","journal-title":"Gut"},{"key":"10.1002\/jmv.23957-BIB0004|jmv23957-cit-0004","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2217\/fmb.09.8","article-title":"HCV genetic variability: From quasispecies evolution to genotype classification","volume":"4","author":"Argentini","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1002\/jmv.23957-BIB0005|jmv23957-cit-0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23957-BIB0006|jmv23957-cit-0006","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2036.2011.04714.x","article-title":"Systematic review: Epidemiology of hepatitis C genotype 6 and its management","volume":"34","author":"Chao","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/jmv.23957-BIB0007|jmv23957-cit-0007","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/hep.24683","article-title":"Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4","volume":"55","author":"De Nicola","year":"2012","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23957-BIB0008|jmv23957-cit-0008","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.meegid.2009.07.011","article-title":"The quasispecies nature and biological implications of the hepatitis C virus","volume":"9","author":"Fishman","year":"2009","journal-title":"Infect Genet Evol"},{"key":"10.1002\/jmv.23957-BIB0009|jmv23957-cit-0009","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1002\/jmv.23957-BIB0010|jmv23957-cit-0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23957-BIB0011|jmv23957-cit-0011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/gut.2010.223495","article-title":"HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy","volume":"60","author":"Hayes","year":"2011","journal-title":"Gut"},{"key":"10.1002\/jmv.23957-BIB0012|jmv23957-cit-0012","doi-asserted-by":"crossref","first-page":"e45698","DOI":"10.1371\/journal.pone.0045698","article-title":"Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: Results from a meta-analysis","volume":"7","author":"Jia","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1002\/jmv.23957-BIB0013|jmv23957-cit-0013","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"10.1002\/jmv.23957-BIB0014|jmv23957-cit-0014","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMra1213651","article-title":"Current and future therapies for hepatitis C virus infection","volume":"368","author":"Liang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1002\/jmv.23957-BIB0015|jmv23957-cit-0015","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2010.05.079","article-title":"An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response","volume":"139","author":"Mangia","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.23957-BIB0016|jmv23957-cit-0016","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1053\/j.gastro.2010.02.009","article-title":"Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin","volume":"138","author":"McCarthy","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.23957-BIB0017|jmv23957-cit-0017","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.24154","article-title":"IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection","volume":"53","author":"Moghaddam","year":"2011","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23957-BIB0018|jmv23957-cit-0018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hep.23624","article-title":"Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes","volume":"52","author":"Montes-Cano","year":"2010","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23957-BIB0019|jmv23957-cit-0019","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/apt.12300","article-title":"Systematic review: Asian patients with chronic hepatitis C infection","volume":"37","author":"Nguyen","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/jmv.23957-BIB0020|jmv23957-cit-0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1002\/jmv.23957-BIB0021|jmv23957-cit-0021","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jvh.12039","article-title":"IL-28B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: A meta-analysis","volume":"20","author":"Rangnekar","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1002\/jmv.23957-BIB0022|jmv23957-cit-0022","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: A genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.23957-BIB0023|jmv23957-cit-0023","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2010.07.041","article-title":"Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients","volume":"54","author":"Sarrazin","year":"2011","journal-title":"J Hepatol"},{"key":"10.1002\/jmv.23957-BIB0024|jmv23957-cit-0024","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jhep.2010.08.024","article-title":"Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin","volume":"54","author":"Scherzer","year":"2011a","journal-title":"J Hepatol"},{"key":"10.1002\/jmv.23957-BIB0025|jmv23957-cit-0025","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.24546","article-title":"Impact of IL28B on treatment outcome in hepatitis C virus G1\/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)\/ribavirin","volume":"54","author":"Scherzer","year":"2011b","journal-title":"Hepatology"},{"key":"10.1002\/jmv.23957-BIB0026|jmv23957-cit-0026","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/jvh.12047","article-title":"Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection","volume":"20","author":"Seto","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1002\/jmv.23957-BIB0027|jmv23957-cit-0027","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cgh.2010.07.019","article-title":"Impact of IL28B genotype on the early and sustained virologic response in treatment-naive patients with chronic hepatitis C","volume":"9","author":"Stattermayer","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1002\/jmv.23957-BIB0028|jmv23957-cit-0028","first-page":"175","article-title":"Seroepidemiology and genotypes of hepatitis C virus in Thailand","volume":"25","author":"Sunanchaikarn","year":"2007","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1002\/jmv.23957-BIB0029|jmv23957-cit-0029","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1002\/jmv.23957-BIB0030|jmv23957-cit-0030","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1002\/jmv.23957-BIB0031|jmv23957-cit-0031","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1002\/jmv.23957-BIB0032|jmv23957-cit-0032","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2010.04.013","article-title":"Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus","volume":"139","author":"Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.23957-BIB0033|jmv23957-cit-0033","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/jmv.23561","article-title":"Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1","volume":"85","author":"Zhang","year":"2013","journal-title":"J Med Virol"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.23957","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jmv.23957\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T15:42:14Z","timestamp":1625326934000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.23957"}},"subtitle":["<i>IFNL3, IFNL4<\/i>SNPs &amp; HCV Treatment in Thais"],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1002\/jmv.23957","relation":{},"ISSN":["0146-6615"],"issn-type":[{"type":"print","value":"0146-6615"}],"subject":[],"published":{"date-parts":[[2014,4,30]]}}}